Investigating and Ranking of Barriers Affecting Development of Pharmaceutical Industry Exports in Iran: AHP Method
Abstract
Background: The study aimed to investigate and rank the barriers affecting the development of pharmaceutical industry exports in Iran's AHP method. Methods: The research applied and descriptive method, a field documentary. The study's statistical population was all pharmaceutical organizations that operate in the direction of export to other countries; the study's statistical population consisted of business managers and professors working in the field of export and marketing managers of exporting pharmaceutical companies. The method of data collection was using a questionnaire. The data analysis method was a hierarchical analysis method using a decision tree. Results: Evaluation of the results obtained for the barrier of workforce and knowledge of indicators of access to specialized and skilled labor in the field of drug production, skills and technical knowledge in the company in innovative design and development of new products, existing knowledge infrastructure for clinical trial studies In the country of origin, access to a specialized and skilled workforce in the field of drug export, the number of academic and research centers in the field of medicine, the relationship of academic and research centers in the field of medicine with industry and access to cheap labor and the necessary knowledge in compiling and collecting documents Necessary for export to target countries were approved. Conclusion: For many firms, the most important external factors that prevent barriers to entering international markets include tariff and non-tariff barriers, foreign exchange rates, fluctuations, competition in foreign markets, government policies, foreign trade practices, and different product and consumption standards. [18] Similarly, operational barriers include the terms of receipt and payment from foreign buyers, establishing transport arrangements, customs clearance, representation, and managing international distribution channels through international markets.Cheraghali A. Trends in Iran pharmaceutical market. Iran J Pharm Res. 2017; 16(1):1-7.
Kahiya, E.T., Five decades of research on export barriers: Review and future directions. International Business Review, 2018. 27(6): p. 1172-1188.
Fernández-Mesa, A. and J. Alegre, Entrepreneurial orientation and export intensity: Examining the interplay of organizational learning and innovation. International Business Review, 2015. 24(1): p. 148-156.
Aghajani, H.A., Farzadfar, Ramin, Model of export performance with the competitive capabilities approach of small and medium enterprises exporting citrus in the northern provinces of Iran. Iranian Journal of Management Science, 2013. 8(29): p. 24-44.
Khani, SNASD, Analyzing the Effect of “Size” and “Export Experience” Factors on Perceived Obstacles of Exports Administrative - Service Activities A Case Study of North-East Cooperatives of Iran. Journal of Cooperatives and Agriculture, 2011. 22(6): p. 59-85.
Sufrin, C.B. and J.S. Ross, Pharmaceutical industry marketing: Understanding its impact on women’s health. Obstetrical & gynecological survey, 2008. 63(9): p. 585-596.
Coculescu, B. et al., Market policy as an innovative element of marketing in the Romanian healthcare services–an approach focused on the patient. Journal of medicine and life, 2015. 8(4): p. 440.
Frootan, V., Evaluation, and ranking of effective factors on innovation capability in the pharmaceutical industry by AHP method Case study: Tehran Drug Company, in International Management Conference Elite. 2016, Institute of Excellence at Karin Conference.
Barbosa, D.M.E., A.H. Ayala, and A.A. Sandoval, The Colombian pharmaceutical industry: Factors affecting export. European journal of management and business economics, 2016. 25(2): p. 39-46.
Mohammadzadeh, M., M. Poloee, and T. Ghari, Export readiness assessment of ten Iranian pharmaceutical companies and comparison with their export performance. Pharmaceutical Sciences, 2016. 22(3): p. 203-209.
imitratos, P., et al., The motivation of international entrepreneurship: The case of Chinese transnational entrepreneurs. International business review, 2016. 25(5): p. 1103-1113.
Kotler, P., Marketing management. 2007: Pearson Italia Spa.
Kakkar, G., H.J. Quesada-Pineda, and R.L. Smith, Increasing Exports of US Wooden Modular Homes to Developing Countries Systems. 2017.
Paeleman, I., C. Fuss, and T. Vanacker, Untangling the multiple effects of slack resources on firms’ exporting behavior. Journal of world business, 2017. 52(6): p. 769-781.
Alvarez, R., Sources of export success in small and medium-sized enterprises: the impact of public programs. International Business Review, 2004. 13(3): p. 383-400.
Harvie, C., D. Narjoko, and S. Oum, Firm characteristic determinants of SME participation in production networks. ERIA discussion paper series, 2010. 11: p. 1-52.
Ortiz, R.F., J.A. Ortiz, and A.M. Ramirez, How does management perceive exporting? An empirical study of SMEs. Engineering Economics, 2012. 23(2): p. 200-208.
Ebrahimi, H.R.Y.M.A.M.M.M., Identifying and Prioritizing the Export Barriers and Proposing Initiatives to Developing Small to Medium Enterprises (SMEs) Export Case Study: Feed Industry in West Azerbaijan. New Marketing Research, 2013. 3(1): p. 139-160.
Kahiya, E.T., Export barriers as liabilities: Near perfect substitutes. European Business Review, 2017.
Vaccarini, K., B. Pojaghi, and S. Yan, EURASIAN JOURNAL OF BUSINESS AND MANAGEMENT. Eurasian Journal of Business and Management, 2019. 7(3): p. 1-14.
Files | ||
Issue | Vol 9 No 1 (2023) | |
Section | Articles | |
DOI | https://doi.org/10.18502/jppm.v9i1.12878 | |
Keywords | ||
pharmaceutical industry exports AHP method |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |